<code id='E43E92A43B'></code><style id='E43E92A43B'></style>
    • <acronym id='E43E92A43B'></acronym>
      <center id='E43E92A43B'><center id='E43E92A43B'><tfoot id='E43E92A43B'></tfoot></center><abbr id='E43E92A43B'><dir id='E43E92A43B'><tfoot id='E43E92A43B'></tfoot><noframes id='E43E92A43B'>

    • <optgroup id='E43E92A43B'><strike id='E43E92A43B'><sup id='E43E92A43B'></sup></strike><code id='E43E92A43B'></code></optgroup>
        1. <b id='E43E92A43B'><label id='E43E92A43B'><select id='E43E92A43B'><dt id='E43E92A43B'><span id='E43E92A43B'></span></dt></select></label></b><u id='E43E92A43B'></u>
          <i id='E43E92A43B'><strike id='E43E92A43B'><tt id='E43E92A43B'><pre id='E43E92A43B'></pre></tt></strike></i>

          entertainment

          entertainment

          author:focus    Page View:4
          A handout illustration representing Google’s DeepMind subsidiary and Isomorphic Labs developed an AI model that can accurately predict how a vast universe of biomolecules interact on an atomic level.
          DeepMind

          Google on Wednesday unveiled an artificial intelligence tool capable of predicting the structure and interaction of a vast universe of biomolecules, a fundamental advance that may help scientists unravel poorly understood aspects of biology and disease.

          The new AI, dubbed AlphaFold 3, improves upon earlier versions of the model by predicting not just the structure of proteins, but all the molecules that interact with them in cells, including RNA, DNA, ions, and other small molecules.

          advertisement

          Most new drugs consist of small molecules designed to bind to a protein involved in disease. AlphaFold 3 opens broader avenues of exploration, allowing scientists to rapidly examine complex interactions with other molecules that may highlight new disease targets — and different ways of attacking them.

          STAT+ Exclusive Story

          Already have an account? Log in

          STAT+

          This article is exclusive to STAT+ subscribers

          Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

          Already have an account? Log in

          Already have an account? Log in

          Monthly

          $39

          Totals $468 per year

          $39/month Get Started

          Totals $468 per year

          Starter

          $30

          for 3 months, then $39/month

          $30 for 3 months Get Started

          Then $39/month

          Annual

          $399

          Save 15%

          $399/year Get Started

          Save 15%

          11+ Users

          Custom

          Savings start at 25%!

          Request A Quote Request A Quote

          Savings start at 25%!

          2-10 Users

          $300

          Annually per user

          $300/year Get Started

          $300 Annually per user

          View All Plans

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          knowledge

          Walensky prepares to leave CDC — and Congress — behind
          Walensky prepares to leave CDC — and Congress — behind

          OutgoingCDCDirectorRochelleWalenskyJIMWATSON/AFPviaGettyImagesRochelleWalensky,theoutgoingdirectorof

          read more
          Sage's campaign to raise awareness of postpartum depression hits a nerve
          Sage's campaign to raise awareness of postpartum depression hits a nerve

          Thecampaignfeatureswomenwithpacifiersintheirmouthsandtheslogan"SilenceSucks."SageTherapeuticsSageThe

          read more
          The cancer drug shortage isn’t new — and neither are the solutions
          The cancer drug shortage isn’t new — and neither are the solutions

          PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

          read more

          The painfully weak evidence on taking collagen to treat arthritis

          Anx-rayshowsnarrowingofthekneejointspace,wherecartilageoncecushionedthejoint.AdobeOneThursdayinSepte